gvtcx

Blood Group Genotyping for Sickle Cell and Thalassaemi

NHS England, Leeds Published 3 Sept 2025 Contracts Finder

key details

Value£140,671
Statuscomplete
Category (CPV) 85111810
Deadline5 May 2025
Contract start12 May 2025
Contract end31 Mar 2026
SME suitableYes
OCIDocds-b5fd17-4ae36907-e480-42d5-845e-5aaee77248d4

Award

SupplierValueDateStatus
NHS BLOOD AND TRANSPLANT (NHSBT) £140,671 12 May 2025 active

description

The main output of this programme is for blood group genotyping to become embedded into routine practice. Primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
3 Sept 2025 Award (award) · d966c341-a622-49a0-b6f4-29dbbc3b93bf-862055

more from NHS England, Leeds

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.